Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease.
E
E
Heinonen
V
V
Myllylä
D000368:Aged; D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001342:Autonomic Nervous System Diseases / Q000139:chemically induced*; D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000294:innervation*; D004359:Drug Therapy, Combination; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D012642:Selegiline / Q000009:adverse effects* / Q000627:therapeutic use; D014636:Valsalva Maneuver / Q000187:drug effects
D000978:Antiparkinson Agents; D012642:Selegiline; D007980:Levodopa